SphK inhibitors, S1P, virtual screening, structure-based drug design, structure activity relationship, anti-prostatic cancer
Alzheimer's disease, Schisandra polysaccharide, metabolomics, lipidomics, mechanism
SphKs inhibitors, S1P, virtual screening, structure-based drug design, structure-activity relationship, anti-prostatic cancer
Sphingosine kinase inhibitors, Computer-aided drug design, S1P, structure-activity relationship
Sphingosine Kinase Inhibitors, K145, anticancer, Structure-activity relationship